Comparative Supervised Machine Learning for Predicting Cardiovascular Disease among Indian Adults 45 Years or Older: Evidence from the LASI Wave 1
Source check: Source checked. Not independent scientific confirmation.
Finding: In LASI Wave 1, a held-out sample of 19,335 adults supported retrospective discrimination of current, survey-defined CVD status (Random Forest AUC 0.728, Brier 0.177). This is a cohort-specific retrospective clinical classification result; it does not establish incident-risk prediction, causation, or external validity. The result is reported in the Research Square preprint. Affiliation was not stated in the reviewed material. It does not establish generalization beyond the reported setting or prospective real-world benefit.
Technology: Supervised classifiers learn from LASI features to classify existing CVD status
Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Supervised classifiers learn from LASI features to classify existing CVD status
- Test and result
- In LASI Wave 1, a held-out sample of 19,335 adults supported retrospective discrimination of current, survey-defined CVD status (Random Forest AUC 0.728, Brier 0.177). This is a cohort-specific retrospective clinical classification result; it does not establish incident-risk prediction, causation, or external validity.
- Limitation / still unknown
- Independent replication and prospective real-world benefit are not established in the reviewed study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.researchsquare.com/article/rs-11390178/v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.